Singapore markets closed

Straits Times Index
3,303.66
+12.96(+0.39%)
S&P 500
5,221.21
-1.47(-0.03%)
Dow
39,506.11
-6.73(-0.02%)
Nasdaq
16,371.71
+30.85(+0.19%)
Bitcoin USD
62,966.72
+1,682.32(+2.75%)
CMC Crypto 200
1,294.69
+34.49(+2.74%)

ETON May 2024 2.500 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

1.1800

0.0000

(0.00%)

As of 03:11PM EDT. Market open.

Simply Wall St.
Eton Pharmaceuticals First Quarter 2024 Earnings: EPS Beats Expectations
Eton Pharmaceuticals ( NASDAQ:ETON ) First Quarter 2024 Results Key Financial Results Revenue: US$7.97m (up 50% from 1Q...
Thomson Reuters StreetEvents
Q1 2024 Eton Pharmaceuticals Inc Earnings Call
Q1 2024 Eton Pharmaceuticals Inc Earnings Call
GlobeNewswire
Eton Pharmaceuticals Reports First Quarter 2024 Financial Results
• Q1 2024 revenue of $8.0 million, representing 50% growth over Q1 2023 and the 13th straight quarter of sequential product sales growth• Acquired PKU GOLIKE®, launched Nitisinone, and submitted a new drug application (NDA) for product candidate ET-400• Management to hold conference call today at 4:30pm ET DEER PARK, Ill., May 09, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commerciali